Home › Kanser sa Suso › Illinois › Champaign

Pag-aaral pangklinika para sa Kanser sa Suso sa Champaign, IL

Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Champaign. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Carle Cancer Center, Urbana · 2 mi ang layo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Nagre-recruitPhase 3

Clinical Trial Site, Urbana · 2 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07085767

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Nagre-recruitPhase 3

Carle Foundation Hospital d/b/a Carle Cancer Center, Urbana · 2 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07173751

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Nagre-recruitPhase 1/2

Carle Cancer Center, Urbana · 2 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT05386108

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Nagre-recruitPhase 3

Carle Cancer Center, Urbana · 2 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06790693

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Nagre-recruitPhase 3

Carle Foundation Cancer Institute-Urbana, Urbana · 2 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06072612

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Nagre-recruitPhase 3

Carle Cancer Center, Urbana · 2 mi ang layo

Edad 18 hanggang 60 · Kababaihan · Na-update Set 2, 2026 · NCT05879926

E-Mindfulness Approaches for Living After Breast Cancer

Nagre-recruitPhase 3

Carle Cancer Center, Urbana · 2 mi ang layo

Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06748222

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Nagre-recruitPhase 3

Carle Cancer Center, Urbana · 2 mi ang layo
The Carle Foundation Hospital, Urbana · 2 mi ang layo

Edad 50 hanggang 70 · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral

Carle Cancer Center, Urbana · 2 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss

Nagre-recruit

Carle Health, Urbana · 2 mi ang layo

Edad 21 pataas · Kababaihan · Na-update Abr 6, 2025 · NCT05484973

Pag-aaral para sa Kanser sa Suso sa ibang lungsod

Iba pang pag-aaral sa Champaign

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.